This inventor holds 45 USPTO granted patents and 8 published patent applications, plus 10 CIPO patents and 19 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: 4Sc Ag, American Cyanamid Company, Basf Aktiengesellschaft. Active years: 1998-2021.
Location History:
- Grunewaldstrasse, DE (1999 - 2000)
- Mainz, DE (1998 - 2005)
- Constance, DE (2010 - 2015)
- Stockach, DE (1998 - 2021)
Company Filing History:
17 out of 52 
12 out of 3,580 
7 out of 10,816 
Years Active: 1998-2021
Areas of Expertise:
Title: Thomas Maier - Innovator in Pharmaceutical Chemistry
Introduction
Thomas Maier, based in Stockach, Germany, is a prominent inventor with a prolific portfolio boasting 45 patents. His contributions particularly shine in the realm of pharmaceutical chemistry, where he focuses on developing novel compounds that hold significant therapeutic potential.
Latest Patents
Among his latest inventions, Maier has made strides in synthesizing crystalline Tafamidis polymorphs. This invention details a new pathway to synthesize these polymorphs starting from a Tafamidis acetic acid adduct. The invention extends to a comprehensive process to create Tafamidis, including its pharmaceutical compositions and therapeutic applications of the new crystalline polymorphs.
Furthermore, Maier's work on substituted imidazoquinolines has opened doors for anticancer treatments. These novel compounds exhibit efficacy as Toll-like Receptor 7 activators, highlighting Maier's commitment to advancing medicine with innovative solutions.
Career Highlights
Throughout his career, Thomas Maier has worked with reputable companies, contributing to the advancement of pharmaceutical innovations. Notably, he has been associated with 4SC AG and American Cyanamid Company. His work in these organizations has fostered significant advancements in drug development and research.
Collaborations
Maier's collaborations are equally noteworthy, particularly with esteemed colleagues such as Stefan Scheiblich and Helmut Siegfried Baltruschat. Together, they have combined their expertise to push the boundaries of pharmaceutical research, leading to impactful breakthroughs in the field.
Conclusion
In conclusion, Thomas Maier stands out as a vital contributor to the world of pharmaceuticals. His innovative approaches to synthesizing new compounds underscore his importance as an inventor. With a robust portfolio and influential collaborations, Maier continues to shape the future of drug development and therapeutic applications, marking him as a key figure in contemporary pharmaceutical chemistry.